A study looked at more than 23,600 Medicare beneficiaries with RA who had received a ≥30-day prescription of an opioid drug. Participants were grouped according to those who had been prescribed a ...
Please provide your email address to receive an email when new articles are posted on . Patients with RA who responded to DMARD therapy showed reduced microbiome levels of certain bacteria. DMARD ...
Use of a tumor necrosis factor inhibitor (TNFi) or triple therapy with conventional, synthetic disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis have similar beneficial effects ...
Researchers found that risk of adverse events and mortality did not increase following certain rheumatoid arthritis (RA) treatments. Among individuals with rheumatoid arthritis (RA), beginning use of ...
One of the most talked about treatments for rheumatoid arthritis (RA) involves the use of disease-modifying antirheumatic drugs or DMARDs. Studies show these medications can actually halt the ...
Please provide your email address to receive an email when new articles are posted on . A review of social media posts by patients with rheumatoid arthritis revealed generally positive opinions about ...
SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...
The treat-to-target approach represented a stepped-up model for chronic disease management that only became possible when the available therapies showed the potential for disease remission. The ...
There are several effective treatments for RA, including DMARDs and biologics. Both types of medications control rheumatoid arthritis by lowering the inflammation that fuels it, but there are ...
Rheumatoid arthritis (RA) inflammation attacks the tissue lining your joints and causes swelling and pain. Inflamed joint tissue breaks down and wears away. Without medications to treat and control RA ...
About one-third of patients prefer in-hospital administration, particularly if they are older or already make frequent visits to the hospital. Most patients with rheumatoid arthritis (RA) would prefer ...
Weaker immune response against COVID-19 may be attributed to the more targeted immunosuppressive mechanism of biologic DMARDs. Rheumatoid arthritis (RA) patients receiving biologic disease-modifying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback